Previous studies already showed that the malignant progression of astrocytoma toward end-stage GBM is accompanied by sequential genetic and epigenetic alterations including the amplification/mutation of the EGFR gene and the hypermethylation of the chromosomal region around the TP53 gene [63]. This evidence concerns the gene TP53 and glioblastoma.